TAILIN BIOTECH released its performance for the first half of the year, with a net profit attributable to the parent company of 13.5429 million yuan, an increase of 105.76%

TAILIN BIOTECH released its 2025 semi-annual report, with operating revenue of 146 million yuan, a year-on-year decrease of 6.69%. The net profit attributable to shareholders was 13.5429 million yuan, a year-on-year increase of 105.76%. The net profit after deducting non-recurring gains and losses was 13.2038 million yuan, a year-on-year increase of 116.80%. The basic earnings per share were 0.11 yuan, and it plans to distribute a cash dividend of 1 yuan (including tax) for every 10 shares to all shareholders